Icatibant Acetate API is a pharmaceutical-grade synthetic peptide and selective bradykinin B2 receptor antagonist used for the treatment of acute attacks of hereditary angioedema (HAE). It blocks the action of bradykinin, a key mediator responsible for swelling and inflammation, providing rapid relief from symptoms associated with hereditary angioedema.
Icatibant Acetate is formulated as a subcutaneous injectable and is widely used in emergency and specialty care for the management of acute HAE episodes. It offers rapid onset of action and targeted therapeutic efficacy.
Manufactured under WHO-GMP-certified facilities, our Icatibant Acetate API provides exceptional purity, stability, and batch-to-batch consistency. Every batch is supplied with complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Icatibant Acetate API is used in injectable formulations for the treatment of acute attacks of hereditary angioedema (HAE).
It selectively blocks bradykinin B2 receptors, preventing bradykinin-induced swelling, pain, and inflammation during HAE attacks.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation.
Yes. We supply Icatibant Acetate API in commercial quantities with worldwide export support.
Get Bulk Quote via WhatsApp